Beacon Biosignals

We develop an AI platform for brain data to accelerate new treatments for patients with neurological and psychiatric diseases. Our platform uses FDA-cleared EEG wearables (like the Dreem 3S headband), machine learning algorithms, and large datasets.

We focus on quantitative sleep analysis, measuring brain activity with EEG technology to identify biomarkers, assess treatment effects, and stratify patients. This helps with psychiatric disorders, neurological disorders, and primary or secondary sleep disorders. We capture and analyze FDA-grade data to develop targeted treatments and expand labeling claims.

Our end-to-end platform offers clinical-grade sleep EEG capture, analytics software for low-latency event monitoring, and full-service clinical trial support from our Clinical Study Operations and Scientific Services teams. We aim to identify dose-dependent drug effects, characterize patient populations for clinical trials and real-world care, expand labeling language using quantitative endpoints, and track disease progression early. We support therapeutic development from translational research to clinical trial optimization and clinical practice. Our products are strictly for clinical trial, diagnostic, and academic use, not for individual consumer purchase.

We were founded in 2019 and operate in the Software Development industry.

Our mission is to accelerate innovation to get life-changing treatments to patients faster. Our core values guide this mission:

• Commitment to Excellence: We work with precision and speed.
• Curiosity Before Conclusions: We prioritize problem-solving over attachment to specific solutions.
• Culture is a Team Sport: We believe strong culture requires active pursuit and shared stewardship.
• Share What You Know: We default to transparency through documentation and public questioning.
• Time is Brain: We move with urgency to achieve faster decisions, trials, and insights.
• Life Outside Work Matters: We protect time for rest and personal life.

Beacon Biosignals has between 51 and 200 employees. The team’s expertise spans neuroscience, machine learning, academic and pharmaceutical research, and product development. The company has a remote-first culture with a globally distributed team, and optional in-person offices in Boston (Headquarters), Paris, New York, and Cleveland. The work environment emphasizes robust asynchronous practices, empathy, curiosity, simplicity, and cross-functional collaboration. Our leadership team includes individuals with backgrounds in neuroscience, machine learning, and clinical medicine.

We offer a total compensation package that includes company equity, paid time off (PTO), and other benefits in addition to base salary. We support remote and hybrid work, with robust asynchronous practices. We also have optional in-person office hubs in Boston, New York City, Paris, and Cleveland. Employees have opportunities for career development and to contribute to clinical research.